1. Volume 3, Issue 8, Pages 730-739 (August 2016)
Pharmacological and psychotherapeutic interventions for management of obsessive- compulsive disorder in adults: a systematic review and network meta-analysis 
Dr Petros Skapinakis, PhD, Deborah M Caldwell, PhD, Prof William Hollingworth, PhD, Peter Bryden, MSc, Naomi A Fineberg, MRCPsych, Prof Paul Salkovskis, PhD, Nicky J Welton, PhD, Helen Baxter, PhD, David Kessler, MRCGP, Prof Rachel Churchill, PhD, Prof Glyn Lewis, PhD 
The Lancet Psychiatry 
Volume 3, Issue 8, Pages (August 2016)
DOI: /S (16)
Copyright © 2016 Skapinakis et al. Open Access article published under the terms of CC BY Terms and Conditions

2. Figure 1 Study selection YBOCS=Yale-Brown Obsessive Compulsive Scale.
The Lancet Psychiatry 2016 3, DOI: ( /S (16) )
Copyright © 2016 Skapinakis et al. Open Access article published under the terms of CC BY Terms and Conditions

3. Figure 2
Network diagram for efficacy analysis representing direct comparisons between individual treatments
The size of each circle is proportional to the number of randomly allocated participants and the width of each line is proportional to the number of trials in each direct comparison. BT=behavioural therapy. CBT=cognitive behavioural therapy. CT=cognitive therapy. BTCLO=behavioural therapy and clomipramine. CBTFLV=cognitive behavioural therapy and fluvoxamine. CIT=citalopram. CLO=clomipramine. ESCIT=escitalopram. FLV=fluvoxamine. FLX=fluoxetine. HYP=hypericum. PAR=paroxetine. PL=placebo. PSYPL=psychological placebo. SER=sertraline. VEN=venlafaxine. WL=waiting list.
The Lancet Psychiatry 2016 3, DOI: ( /S (16) )
Copyright © 2016 Skapinakis et al. Open Access article published under the terms of CC BY Terms and Conditions